ICD Therapy was associated with a significantly reduced risk of death: ... ICD Therapy had significant benefit in patients with NYHA class II CHF, but no ...
We studied survival following Medtronic Sprint lead implant, and found that year ... Sprint 6945 and Quattro 6947 leads (Q) were released 7 and 3 years prior ...
North West London implant rate in 2005 was around 80 (for a 1.8 million ... make the distinction between perceived impending cardiac death and non-cardiac death ...
On optimal medical therapy for 3 months. Appropriate dose of ACE-I. Beta blocker, if tolerated ... Chest radiography. Drugs if required: beta blocker, ACE-I, ...